ʳ¹ÜÖ×Áö/·ÅÉäÁÆ·¨,Esophageal neoplasms/radiotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐØÜÕÁ×Ëữø,Thymidine phosphorylaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ȫֱ³¦ÏµÄ¤ÇгýÊõ,Total mesorectal excisionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ô­·¢ÐÔ¸Îϸ°û°©,Primary hepatocellular carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ÎÖ×Áö/²¡Àíѧ,liver neoplasms/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼äÖÊÁö,Stromal tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ïû»¯ÏµÍ³Ö×Áö,digestive system neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ʳ¹ÜÖ×Áö/Ò©ÎïÁÆ·¨,esophageal neoplasms/drug therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½áÖ±³¦Ö×Áö/²¡Àíѧ,colorectal neoplasms/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ǰÉÚÁܰͽá»î×éÖ¯¼ì²é,Sentinel lymph node biopsyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÔÓºÏ×Ó¶ªÊ§,Loss of heterozygosityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« CT¹à×¢³ÉÏñ,CT perfusion imagingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« θÖ×Áö/²¡Àíѧ,stomach neoplasms/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×Ôɱ»ùÒòÖÎÁÆ,Suicide gene therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ê®¶þÖ¸³¦Ö×Áö,duodenal neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µÍÉø,low permeabilityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 賦µÀ¼äÖÊÖ×Áö,Gastrointestinal stromal tumorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« cyclinE,Cyclin EÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ȫֱ³¦ÏµÄ¤Çгý,total mesorectal excisionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½þÈó×ªÒÆ,Invasion and metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ѫ¹ÜÇòÁö,glomus tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±½¶¡ËáÄÆ,sodium phenylbutyrateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´ó³¦ÏÙ°©,colorectal adenocarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ñªß²ßøÑÜÉúÎï,Hematoporphyrin derivativeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²ãÕ³Á¬µ°°×ÊÜÌå,laminin receptorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éñ¾­ÄÚ·ÖÃÚ°©,neuroendocrine carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ÎÖ×Áö/¼Ì·¢ÐÔ,Liver Neoplasms/secondaryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ʳ¹ÜÖ×Áö/»¯Ñ§ÁÆ·¨,Esophageal neoplasms/chemotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Õýµç×Ó·¢Éä¶Ï²ã,Positron emission tomographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·ÂÕæÄÚ¾µ,Virtual endoscopyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Êõǰ»¯ÁÆ,Preoperative chemotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÈÏÙÖ×Áö/²¡Àíѧ,pancreatic neoplasms/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸¹Ä¤ºóÖ×Áö,Retroperitoneal tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« DNAÖ¸Êý,DNA indexÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·ÅÉäÖ×Áöѧ,Radiation oncologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁܰͽáÇåɨ,lymphadenectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²Ðθ°©,gastric stump carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« E1A»ùÒò,E1A geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ô­·¢ÐÔ¸¹Ä¤ºóÖ×Áö,primary retroperitoneal tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ò¸ÎÑÁܰͽá,axillary lymph nodeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ʾ×Ù¼¼Êõ,tracer techniqueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁÛ°©,squamous cell carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶þÏ©±û»ùÈýÁò,diallyl trisulfideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸¹Ä¤×ªÒÆ,Peritoneal metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·´Òå»ùÒòÖÎÁÆ,antisense gene therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´¿ºÏÐÔȱʧ,Homozygous deletionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸»ÎøÂóÑ¿,selenium-enriched maltÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´íÅäÐÞ¸´»ùÒò,Mismatch repair geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸Îº£Ãà״Ѫ¹ÜÁö,hepatic cavernous hemangiomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« θÖ×Áö/ÒÅ´«Ñ§,stomach neoplasms/geneticsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÈÏÙÖ×Áö/·ÅÉäÁÆ·¨,pancreatic neoplasms/radiotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« и¨ÖúÖÎÁÆ,Neoadjuvant therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸¹Ç»ÄÚ»¯ÁÆ,Intraperitoneal chemotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ÎÄÚµ¨¹Ü°©,Intrahepatic cholangiocarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« NGX6»ùÒò,NGX6 geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁܰͽáÎ¢×ªÒÆ,lymph node micrometastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼¤ËØÊÜÌå,hormone receptorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« EC9706ϸ°û,EC9706 cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈËÌå×é³É,Body compositionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ʾ·¶»ùµØ,demonstration baseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éñ¾­½þÈó,Perineural invasionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« θÖ×Áö/»¯Ñ§ÁÆ·¨,Stomach neoplasms/chemotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½áÖ±³¦Ö×Áö/Ò©ÎïÁÆ·¨,colorectal neoplasms/drug therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö×Áö¸¨ÖúÁÆ·¨,Neoadjuvant TherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½áÖ±³¦Ö×Áö/»¯Ñ§ÁÆ·¨,Colorectal neoplasms/chemotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²àÏò·¢ÓýÐÍÖ×Áö,Laterally spreading tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΢²¨¹Ì»¯,microwave coagulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ì«ÐÐÉ½Çø,Taihang mountain areaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΢²¨Äý¹Ì,Microwave coagulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÅ´«ÐÔ·ÇÏ¢ÈⲡÐÔ½áÖ±³¦°©,Hereditary nonpolyposis colorectal cancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÖ×Áö/²¡Àíѧ,kidney neoplasms/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ϸ°ûÖ§¼Üµ°°×ÖÊÀà,cytoskeletal proteinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈËÀàÈéÍ·×´Áö²¡¶¾,Human papillomavirusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »·¾³Î£ÏÕÒòËØ,environmental risk factorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÇÖÏ®Óë×ªÒÆ,Invasion and metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Êõǰ·ÅÁÆ,Preoperative radiotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁܰͿ×,lymphatic stomataÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·´ÒåÖÎÁÆ,antisense therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶þÁÑÒøÐÓ,Ginkgo bilobaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶ñÐÔµ¨µÀ¹£×è,Malignant biliary obstructionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ°°×ÖÊP21,protein P21Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ñ¡ÔñÐÔ¼ôÇÐ,alternative splicingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« θÖ×Áö/Á÷Ðв¡Ñ§,stomach neoplasms/epidemiologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈÈÐݿ˵°°×Àà,Heat shock proteinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ÎÖ×Áö/ÃâÒßѧ,liver neoplasms/immunologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ïٹܿª¿Ú,pit patternÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·´Ïò´«²¥Éñ¾­ÍøÂç,BP neural networkÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂÌÉ«Êß²Ë,green vegetableÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« M´øÐ¡²¨±ä»»,M-band wavelet transformÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ki67µ°°×,Ki67 proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ǰÇгýÊõ,anterior resectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÔÓºÏȱʧ,loss of heterozygosityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« HepG2ϸ°ûϵ,HepG2 cell lineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éñ¾­ÇÖÏ®,Neural invasionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« пָ,Zinc fingerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´Å°ÐÏò,magnetic targetingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« PET,poly(ethylene terephthalate)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹£×èÐԻƾÒ,Obstructive jaundiceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ʳ¹ÜÖ×Áö/ÒÅ´«Ñ§,esophageal neoplasms/geneticsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×ªÒÆÐÔ½áÖ±³¦°©,Metastatic colorectal cancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«